Vascular Pharmacology

Papers
(The H4-Index of Vascular Pharmacology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Endothelial dysfunction in acute and long standing COVID−19: A prospective cohort study78
Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage74
Extracellular vesicles and cardiovascular system: Biomarkers and Cardioprotective Effectors69
SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells64
Endothelial cells and SARS-CoV-2: An intimate relationship51
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies34
Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis33
Perivascular adipose-derived exosomes reduce macrophage foam cell formation through miR-382-5p and the BMP4-PPARγ-ABCA1/ABCG1 pathways31
Nectin-4 promotes lymphangiogenesis and lymphatic metastasis in breast cancer by regulating CXCR4-LYVE-1 axis29
Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome28
Circular RNA circ_0029589 regulates proliferation, migration, invasion, and apoptosis in ox-LDL-stimulated VSMCs by regulating miR-424-5p/IGF2 axis26
A possible role for ST2 as prognostic biomarker for COVID-1922
A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications22
The short-chain fatty acid butyrate accelerates vascular calcification via regulation of histone deacetylases and NF-κB signaling22
Diabetic neuropathy: Molecular approach a treatment opportunity20
Angiotensin-II activates vascular inflammasome and induces vascular damage20
Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency19
Extracellular vesicles (EVs) in ischemic conditioning and angiogenesis: Focus on endothelial derived EVs19
Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation19
0.052039861679077